Last reviewed · How we verify

NCT06177834

Alisklamp and Dorsal Slit Sleeve Circumcision

Completed NA Last updated 16 April 2024
What this trial tests

NA trial testing Alisklamp in Circumcision in 180 participants. Completed in 1 March 2024.

Timeline
20 December 2023
Primary endpoint
20 January 2024
1 March 2024

Quick facts

Lead sponsorMustafa Azizoğlu
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposetreatment
Enrollment180
Start date20 December 2023
Primary completion20 January 2024
Estimated completion1 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mustafa Azizoğlu — full company profile →

Who can join

Adults 1 Minute to 18, male only, with Circumcision. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the plan is to compare the circumcision performed with Alisklamp versus Dorsal Slit Sleeve method in terms of age, co-existing health conditions, surgery time, recovery period, tissue edema and bleeding, postoperative infection, wound healing, wound dehiscence, skin tunnel, and overall complications.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Alisklamp versus Conventional Dorsal Slit Circumcision: A Multicentric Randomized Controlled Trial.
    Azizoglu M, Risteski T, Klyuev S. · · 2024 · cited 4× · PMID 39124835 · DOI 10.3390/jcm13154568

Verify or expand the search:

Other recruiting trials for Circumcision

Currently open trials in the same condition.

Other Mustafa Azizoğlu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06177834.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing